Production (Stage)
Jasper Therapeutics, Inc.
JSPR
$6.01
$0.315.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.24M | -24.32M | -18.64M | -14.58M | -13.73M |
| Total Depreciation and Amortization | 279.00K | 245.00K | 541.00K | 299.00K | 288.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.00M | 2.11M | 2.10M | 1.60M | 1.29M |
| Change in Net Operating Assets | -3.88M | 831.00K | 1.94M | 1.00M | -3.58M |
| Cash from Operations | -22.84M | -21.13M | -14.05M | -11.68M | -15.74M |
| Capital Expenditure | -- | -96.00K | -274.00K | -157.00K | -25.00K |
| Sale of Property, Plant, and Equipment | 4.00K | 20.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 4.00K | -76.00K | -274.00K | -157.00K | -25.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 345.00K | 9.00K | 181.00K | 47.35M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 345.00K | 9.00K | 181.00K | 47.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.84M | -20.87M | -14.32M | -11.66M | 31.59M |